In this regard, previous reports have showed that DFO IV infusion rapidly clears around one third of the non-transferrin-bound iron in the blood [46,47] and reduces intracellular labile iron stores in breast cancer cells [48]. This evidence concerns the gene TF and breast carcinoma.